Trials / Terminated
TerminatedNCT01926769
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and efficacy of second-line treatment with Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the second line treatment of advanced colorectal cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-08-21
- Last updated
- 2018-05-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01926769. Inclusion in this directory is not an endorsement.